Author

Bamdad Zareh

University of California San Diego

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

Dina V. HingoraniiD· 1 shared Jacqueline Lesperance· 1 shared Jorge Silvio GutkindiD· 1 shared Kanika DhawaniD· 1 shared Mahsa MortajaiD· 1 shared Maria F. CamargoiD· 1 shared Michael M. AllevatoiD· 1 shared Ming ChengiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Dina V. HingoraniORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Orthogonally targeted tumor radiosensitization using cell penetrating peptide-ATM inhibitor conjugates to stimulate anti-tumor immune responses

Kanika Dhawan, Michael M. Allevato, Jacqueline Lesperance, Maria F. Camargo, Ming Cheng, Mahsa Mortaja, Bamdad Zareh, Dina V. Hingorani, Stephen Adams, Jorge Silvio Gutkind, Sunil J. Advani

This paper develops a targeted radiosensitizer drug conjugate that enhances tumor control and immune responses while minimizing toxicity to normal tissues.

Cancer Letters · Jun 20, 2026Peer-reviewedPharmacology & Toxicology